Page last updated: 2024-10-23

biperiden and Chronic Illness

biperiden has been researched along with Chronic Illness in 10 studies

Biperiden: A muscarinic antagonist that has effects in both the central and peripheral nervous systems. It has been used in the treatment of arteriosclerotic, idiopathic, and postencephalitic parkinsonism. It has also been used to alleviate extrapyramidal symptoms induced by phenothiazine derivatives and reserpine.
biperiden : A member of the class of piperidines that is N-propylpiperidine in which the methyl hydrogens have been replaced by hydroxy, phenyl, and 5-norbornen-2-yl groups. A muscarinic antagonist affecting both the central and peripheral nervous systems, it is used in the treatment of all forms of Parkinson's disease.

Research Excerpts

ExcerptRelevanceReference
" Efficacy of ziprasidone (80-160 mg/d) and olanzapine 10-20 mg was measured using the Positive and Negative Syndrome Scale (PANSS), the Clinical Global Impression (CGI) Scale, the Calgary Depression Scale for Schizophrenia (CDSS), and the Heinrich Quality of Life Scale (HQLS); tolerability assessments included laboratory assessments, body weight, and electroencephalogram."9.15Ziprasidone vs olanzapine in recent-onset schizophrenia and schizoaffective disorder: results of an 8-week double-blind randomized controlled trial. ( Buitelaar, JK; Grootens, KP; Kahn, RS; Peuskens, J; Sabbe, BG; Thys, E; van Veelen, NM; Verkes, RJ, 2011)
" Efficacy of ziprasidone (80-160 mg/d) and olanzapine 10-20 mg was measured using the Positive and Negative Syndrome Scale (PANSS), the Clinical Global Impression (CGI) Scale, the Calgary Depression Scale for Schizophrenia (CDSS), and the Heinrich Quality of Life Scale (HQLS); tolerability assessments included laboratory assessments, body weight, and electroencephalogram."5.15Ziprasidone vs olanzapine in recent-onset schizophrenia and schizoaffective disorder: results of an 8-week double-blind randomized controlled trial. ( Buitelaar, JK; Grootens, KP; Kahn, RS; Peuskens, J; Sabbe, BG; Thys, E; van Veelen, NM; Verkes, RJ, 2011)
"Penfluridol has the clear practical advantage of being the only long-acting drug for oral administration so far available."1.26Controlled trial of penfluridol and thiothixene in the maintenance treatment of chronic schizophrenic syndromes. ( Edenius, B; Jacobsson, L; Kettner, B; Magnusson, KE; Mattsson, B; Perris, C; Rapp, W; Villemoes, P; Von Knorring, L, 1976)

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19904 (40.00)18.7374
1990's4 (40.00)18.2507
2000's0 (0.00)29.6817
2010's2 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bittencourt, S1
Ferrazoli, E1
Valente, MF1
Romariz, S1
Janisset, NRLL1
Macedo, CE1
Antonio, BB1
Barros, V1
Mundim, M1
Porcionatto, M1
Aarão, MC1
Miranda, MF1
Rodrigues, AM1
de Almeida, AG1
Longo, BM1
Mello, LE1
Grootens, KP1
van Veelen, NM1
Peuskens, J1
Sabbe, BG1
Thys, E1
Buitelaar, JK1
Verkes, RJ1
Kahn, RS1
Silver, H1
Geraisy, N1
Meszaros, K1
Lenzinger, E1
Hornik, K1
Schönbeck, G1
Hatzinger, R1
Langer, G1
Sieghart, W1
Aschauer, HN1
Higuchi, H1
Kamata, M1
Yoshimoto, M1
Shimisu, T1
Hishikawa, Y1
Jacobsson, L1
Von Knorring, L1
Mattsson, B1
Perris, C1
Rapp, W1
Edenius, B1
Kettner, B1
Magnusson, KE1
Villemoes, P1
Westphal, KP1
Grözinger, B1
Diekmann, V1
Scherb, W1
Reess, J1
Leibing, U1
Kornhuber, HH1
Klett, CJ1
Caffey, E1
Simpson, GM1
Beckles, D1
Isalski, Z1
Lee, JH1
Kurland, AA1
Dim, BH1
Olsson, JE1

Clinical Trials (2)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Biperiden for Prevention of Epilepsy in Patients With Traumatic Brain Injury[NCT04945213]Phase 3312 participants (Anticipated)Interventional2023-01-10Recruiting
A Multicenter, Double-Blind, Randomized Trial Of Ziprasidone (80 - 160 Mg) Versus Olanzapine (10 - 20 Mg) In Patients With Recent-Onset Schizophrenia, Schizoaffective And Schizophreniform Disorder.[NCT00145444]Phase 3100 participants Interventional2003-03-31Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trials

6 trials available for biperiden and Chronic Illness

ArticleYear
Ziprasidone vs olanzapine in recent-onset schizophrenia and schizoaffective disorder: results of an 8-week double-blind randomized controlled trial.
    Schizophrenia bulletin, 2011, Volume: 37, Issue:2

    Topics: Adult; Alanine Transaminase; Antipsychotic Agents; Aspartate Aminotransferases; Basal Ganglia Diseas

2011
No difference in the effect of biperiden and amantadine on negative symptoms in medicated chronic schizophrenic patients.
    Biological psychiatry, 1995, Sep-15, Volume: 38, Issue:6

    Topics: Adult; Amantadine; Basal Ganglia Diseases; Biperiden; Chronic Disease; Cross-Over Studies; Dopamine

1995
Biperiden and haloperidol plasma levels and extrapyramidal side effects in schizophrenic patients.
    Neuropsychobiology, 1997, Volume: 36, Issue:2

    Topics: Adult; Aged; Anti-Dyskinesia Agents; Antipsychotic Agents; Basal Ganglia Diseases; Biperiden; Chroni

1997
Panic attacks in patients with chronic schizophrenia: a complication of long-term neuroleptic treatment.
    Psychiatry and clinical neurosciences, 1999, Volume: 53, Issue:1

    Topics: Adult; Antipsychotic Agents; Biperiden; Chlorpromazine; Chronic Disease; Depression; Female; Humans;

1999
Evaluating the long-term need for antiparkinson drugs by chronic schizophrenics.
    Archives of general psychiatry, 1972, Volume: 26, Issue:4

    Topics: 1-Propanol; Adult; Antiparkinson Agents; Basal Ganglia Diseases; Benztropine; Biperiden; Chronic Dis

1972
Some methodological considerations in the evaluation of drug-induced extrapyramidal disorders: a study of Ex10-029, a new morphanthridine derivative.
    The Journal of clinical pharmacology and new drugs, 1972, Volume: 12, Issue:4

    Topics: Adult; Antiparkinson Agents; Basal Ganglia Diseases; Biperiden; Chronic Disease; Clinical Trials as

1972

Other Studies

4 other studies available for biperiden and Chronic Illness

ArticleYear
Modification of the natural progression of epileptogenesis by means of biperiden in the pilocarpine model of epilepsy.
    Epilepsy research, 2017, Volume: 138

    Topics: Action Potentials; Animals; Autonomic Nervous System; Biperiden; Chronic Disease; Cytokines; Disease

2017
Controlled trial of penfluridol and thiothixene in the maintenance treatment of chronic schizophrenic syndromes.
    Acta psychiatrica Scandinavica, 1976, Volume: 54, Issue:2

    Topics: Adolescent; Adult; Aged; Biperiden; Chlorpromazine; Chronic Disease; Drug Evaluation; Female; Humans

1976
Slower theta activity over the midfrontal cortex in schizophrenic patients.
    Acta psychiatrica Scandinavica, 1990, Volume: 81, Issue:2

    Topics: Adult; Biperiden; Chronic Disease; Drug Therapy, Combination; Electroencephalography; Female; Fronta

1990
The effectiveness of parenteral administration of fluphenazine decanoate in the treatment of chronic schizophrenics.
    Diseases of the nervous system, 1970, Volume: 31

    Topics: Administration, Oral; Adult; Biperiden; Chronic Disease; Female; Fluphenazine; Humans; Infusions, Pa

1970